NCT02311361 2021-04-20Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic CancerNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed65 enrolled 17 charts